Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones.

PubWeight™: 2.76‹?› | Rank: Top 1%

🔗 View Article (PMID 11994393)

Published in J Clin Endocrinol Metab on May 01, 2002

Authors

Michael Rosenbaum1, Ellen M Murphy, Steven B Heymsfield, Dwight E Matthews, Rudolph L Leibel

Author Affiliations

1: Columbia University, New York, New York, USA.

Associated clinical trials:

Leptin in Human Energy and Neuroendocrine Homeostasis | NCT00265980

Articles citing this

Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22

The metabolic consequences of sleep deprivation. Sleep Med Rev (2007) 6.07

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest (2002) 5.83

Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci (2008) 4.01

Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest (2005) 3.10

Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab (2010) 2.79

The geometry of leptin action in the brain: more complicated than a simple ARC. Cell Metab (2009) 2.69

The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest (2003) 2.42

Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad Sci U S A (2004) 2.03

Appetite control and energy balance regulation in the modern world: reward-driven brain overrides repletion signals. Int J Obes (Lond) (2009) 1.84

Independent circadian and sleep/wake regulation of adipokines and glucose in humans. J Clin Endocrinol Metab (2005) 1.81

Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology (2010) 1.77

Biology's response to dieting: the impetus for weight regain. Am J Physiol Regul Integr Comp Physiol (2011) 1.53

Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. Proc Natl Acad Sci U S A (2005) 1.52

Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring) (2009) 1.51

Genetic approaches to understanding human obesity. J Clin Invest (2011) 1.50

Molecular mapping of mouse brain regions innervated by leptin receptor-expressing cells. Brain Res (2011) 1.46

Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. Proc Natl Acad Sci U S A (2006) 1.46

Human obesity: a heritable neurobehavioral disorder that is highly sensitive to environmental conditions. Diabetes (2008) 1.41

Lifestyle and pharmacological approaches to weight loss: efficacy and safety. J Clin Endocrinol Metab (2008) 1.30

Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab (2011) 1.29

Effects of chronic weight perturbation on energy homeostasis and brain structure in mice. Am J Physiol Regul Integr Comp Physiol (2011) 1.25

Challenges and opportunities of defining clinical leptin resistance. Cell Metab (2012) 1.21

Leptin reverses declines in satiation in weight-reduced obese humans. Am J Clin Nutr (2012) 1.19

Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss. Metabolism (2011) 1.17

Why some of us get fat and what we can do about it. J Physiol (2007) 1.13

Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormone. J Clin Invest (2004) 1.13

Physiological role for leptin in the control of thermal conductance. Mol Metab (2016) 1.11

Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev (2013) 1.10

The use of biosimulation in the design of a novel multilevel weight loss maintenance program for overweight children. Obesity (Silver Spring) (2010) 1.07

Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs. Front Neuroendocrinol (2010) 1.05

Revisiting leptin's role in obesity and weight loss. J Clin Invest (2008) 1.02

Leptin: at the crossroads of energy balance and systemic inflammation. Prog Lipid Res (2006) 1.02

Effects of ambient temperature on adaptive thermogenesis during maintenance of reduced body weight in mice. Am J Physiol Regul Integr Comp Physiol (2012) 1.01

Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. Cell Metab (2016) 1.00

Weight loss maintenance in African American women: a systematic review of the behavioral lifestyle intervention literature. J Obes (2013) 0.98

Chronic AMP-kinase activation with AICAR reduces adiposity by remodeling adipocyte metabolism and increasing leptin sensitivity. J Lipid Res (2011) 0.98

Effects of weight loss and leptin on skeletal muscle in human subjects. Am J Physiol Regul Integr Comp Physiol (2011) 0.97

Maintenance of the thyroid axis during diet-induced obesity in rodents is controlled at the central level. Am J Physiol Endocrinol Metab (2010) 0.94

The loss of metabolic control on alcohol drinking in heavy drinking alcohol-dependent subjects. PLoS One (2012) 0.93

Pharmacogenetics of antipsychotic-induced weight gain. Psychopharmacology (Berl) (2004) 0.92

Effect of physical activity on weight loss, energy expenditure, and energy intake during diet induced weight loss. Obesity (Silver Spring) (2013) 0.92

NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways. Cell Metab (2011) 0.91

Comparative endocrinology of leptin: assessing function in a phylogenetic context. Gen Comp Endocrinol (2014) 0.91

The role of leptin in glucose homeostasis. J Diabetes Investig (2012) 0.90

Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions. Endocr Rev (2013) 0.90

Hypothalamic gliosis associated with high-fat diet feeding is reversible in mice: a combined immunohistochemical and magnetic resonance imaging study. Endocrinology (2014) 0.89

The emerging science of body weight regulation and its impact on obesity treatment. J Clin Invest (2003) 0.88

Bioenergetic impact of tissue-specific regulation of iodothyronine deiodinases during nutritional imbalance. J Bioenerg Biomembr (2011) 0.88

The fall in leptin concentration is a major determinant of the metabolic adaptation induced by caloric restriction independently of the changes in leptin circadian rhythms. J Clin Endocrinol Metab (2011) 0.86

Randomized double-blind placebo-controlled study of leptin administration after gastric bypass. Obesity (Silver Spring) (2013) 0.86

New pharmacological perspectives for the leptin receptor in the treatment of obesity. Front Endocrinol (Lausanne) (2014) 0.86

Caloric restriction chronically impairs metabolic programming in mice. Diabetes (2012) 0.86

The adaptive metabolic response to exercise-induced weight loss influences both energy expenditure and energy intake. Eur J Clin Nutr (2014) 0.85

Metabolic adaptation following massive weight loss is related to the degree of energy imbalance and changes in circulating leptin. Obesity (Silver Spring) (2014) 0.85

Melanocortin-3 receptors and metabolic homeostasis. Prog Mol Biol Transl Sci (2013) 0.84

The central effects of thyroid hormones on appetite. J Thyroid Res (2011) 0.83

Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects. Int J Obes (Lond) (2013) 0.83

Pharmacotherapy for childhood obesity: present and future prospects. Int J Obes (Lond) (2012) 0.83

Novel strategy for the use of leptin for obesity therapy. Expert Opin Biol Ther (2011) 0.83

Influence of interleukin-6 and G174C polymorphism in IL-6 gene on obesity and energy balance. Eur J Med Res (2010) 0.83

A missing link in body weight homeostasis: the catabolic signal of the overfed state. Cell Metab (2014) 0.82

The role of uncoupling protein 3 in human physiology. J Clin Invest (2003) 0.81

Nuclear Factor-Y is an adipogenic factor that regulates leptin gene expression. Mol Metab (2015) 0.80

The dilemma of the nonthyroidal illness syndrome. Acta Biomed (2008) 0.80

Chronic CNS oxytocin signaling preferentially induces fat loss in high-fat diet-fed rats by enhancing satiety responses and increasing lipid utilization. Am J Physiol Regul Integr Comp Physiol (2016) 0.80

[Atypical antipsychotics and metabolic syndrome]. Wien Med Wochenschr (2007) 0.80

Repletion of TNFα or leptin in calorically restricted mice suppresses post-restriction hyperphagia. Dis Model Mech (2011) 0.80

The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol (2017) 0.77

Obesity pharmacotherapy: current perspectives and future directions. Curr Cardiol Rev (2013) 0.77

Leptin Is Required for Glucose Homeostasis after Roux-en-Y Gastric Bypass in Mice. PLoS One (2015) 0.77

Recombinant human leptin does not alter gut hormone levels after gastric bypass but may attenuate sweet cravings. Int J Endocrinol (2014) 0.77

Influence of proinflammatory cytokine gene polymorphism on childhood obesity. Eur J Med Res (2009) 0.77

Mediatory effect of circulating vaspin on resting metabolic rate in obese individuals. Eur J Nutr (2015) 0.76

The neuroendocrinology and neuroscience of energy balance. Front Neuroendocrinol (2009) 0.76

Neural Control of Energy Expenditure. Handb Exp Pharmacol (2016) 0.76

The Effects of Intensive Weight Reduction on Body Composition and Serum Hormones in Female Fitness Competitors. Front Physiol (2017) 0.75

Weight Perturbation Alters Leptin Signal Transduction in a Region-Specific Manner throughout the Brain. PLoS One (2017) 0.75

Suppressed sympathetic outflow to skeletal muscle, muscle thermogenesis, and activity energy expenditure with calorie restriction. Physiol Rep (2017) 0.75

Leptin and its emerging role in children and adolescents. Clin Pediatr Endocrinol (2006) 0.75

The Impact of Bariatric Surgery on Thyroid Function and Medication Use in Patients with Hypothyroidism. Obes Surg (2017) 0.75

Articles by these authors

Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med (2003) 10.84

CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44

Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension (2006) 8.72

Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc (2002) 8.28

Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep (2005) 8.15

Myths, presumptions, and facts about obesity. N Engl J Med (2013) 5.39

The long-term stability of the human gut microbiota. Science (2013) 5.15

Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med (2008) 4.85

Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS One (2009) 4.29

Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr (2002) 4.20

Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep (2007) 4.14

Human oocytes reprogram somatic cells to a pluripotent state. Nature (2011) 4.03

Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol (1985) (2004) 3.59

Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol (2008) 3.49

Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A (2009) 3.43

Development of bioelectrical impedance analysis prediction equations for body composition with the use of a multicomponent model for use in epidemiologic surveys. Am J Clin Nutr (2003) 3.40

Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr (2005) 3.40

Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr (2002) 3.33

Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest (2005) 3.10

A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Genome Res (2011) 3.00

Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr (2002) 2.96

Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr (2014) 2.95

Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab (2010) 2.79

Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr (2003) 2.78

Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science (2008) 2.67

QDR 4500A dual-energy X-ray absorptiometer underestimates fat mass in comparison with criterion methods in adults. Am J Clin Nutr (2005) 2.66

Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr (2004) 2.57

A computational model to determine energy intake during weight loss. Am J Clin Nutr (2010) 2.55

Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A (2006) 2.51

Energy balance and its components: implications for body weight regulation. Am J Clin Nutr (2012) 2.51

Functional analyses of variants reveal a significant role for dominant negative and common alleles in oligogenic Bardet-Biedl syndrome. Proc Natl Acad Sci U S A (2010) 2.45

Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest (2008) 2.44

Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal Chem (2004) 2.40

Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors. Am J Clin Nutr (2005) 2.30

Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. Am J Physiol Regul Integr Comp Physiol (2003) 2.28

Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr (2007) 2.21

Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods. PLoS One (2009) 2.21

Adipose tissue quantification by imaging methods: a proposed classification. Obes Res (2003) 2.19

Is the energy homeostasis system inherently biased toward weight gain? Diabetes (2003) 2.14

Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr (2008) 2.13

Air displacement plethysmography: validation in overweight and obese subjects. Obes Res (2005) 2.07

Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care (2006) 2.04

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults. Cell Metab (2006) 2.02

Is percentage body fat differentially related to body mass index in Hispanic Americans, African Americans, and European Americans? Am J Clin Nutr (2003) 2.01

Waist circumference correlates with metabolic syndrome indicators better than percentage fat. Obesity (Silver Spring) (2006) 2.00

11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med (2009) 1.99

Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample. Sleep (2008) 1.98

Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study. J Acquir Immune Defic Syndr (2007) 1.98

Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. JAMA (2003) 1.97

The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake. Cell Metab (2008) 1.94

Waist Circumference and Cardiometabolic Risk: a Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring) (2007) 1.87

Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism (2004) 1.87

Canaries in the coal mine: a cross-species analysis of the plurality of obesity epidemics. Proc Biol Sci (2010) 1.86

Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care (2007) 1.85

Comparison of dual-energy x-ray absorptiometric and anthropometric measures of adiposity in relation to adiposity-related biologic factors. Am J Epidemiol (2010) 1.84

Self-report-based estimates of energy intake offer an inadequate basis for scientific conclusions. Am J Clin Nutr (2013) 1.79

Percentage body fat ranges associated with metabolic syndrome risk: results based on the third National Health and Nutrition Examination Survey (1988-1994). Am J Clin Nutr (2003) 1.75

Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring) (2011) 1.73

Changes in childhood food consumption patterns: a cause for concern in light of increasing body weights. Am J Clin Nutr (2003) 1.72

Comparison of visceral adipose tissue mass in adult African Americans and whites. Obes Res (2005) 1.71

To eat or not to eat - how the gut talks to the brain. N Engl J Med (2003) 1.68

Waist circumference and abdominal adipose tissue distribution: influence of age and sex. Am J Clin Nutr (2005) 1.64

Comparison of dual-energy X-ray absorptiometry and magnetic resonance imaging-measured adipose tissue depots in HIV-infected and control subjects. Am J Clin Nutr (2008) 1.63

Predictors of attrition and weight loss success: Results from a randomized controlled trial. Behav Res Ther (2009) 1.59

Intermuscular adipose tissue-free skeletal muscle mass: estimation by dual-energy X-ray absorptiometry in adults. J Appl Physiol (1985) (2004) 1.57

Measurement of percentage of body fat in 411 children and adolescents: a comparison of dual-energy X-ray absorptiometry with a four-compartment model. Pediatrics (2004) 1.55

A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children. J Clin Invest (2011) 1.55

Does body mass index adequately convey a patient's mortality risk? JAMA (2013) 1.54

Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care (2004) 1.54

Measurement of the isotope enrichment of stable isotope-labeled proteins using high-resolution mass spectra of peptides. Anal Chem (2005) 1.52

Reprogramming within hours following nuclear transfer into mouse but not human zygotes. Nat Commun (2011) 1.49

Predicting fat percent by skinfolds in racial groups: Durnin and Womersley revisited. Med Sci Sports Exerc (2011) 1.48

Total-body skeletal muscle mass: estimation by dual-energy X-ray absorptiometry in children and adolescents. Am J Clin Nutr (2006) 1.48

Volume estimates by imaging methods: model comparisons with visible woman as the reference. Obes Res (2003) 1.46

Dietary fat is not a major determinant of body fat. Am J Med (2002) 1.46

Determinants of leptin gene expression in fat depots of lean mice. Am J Physiol Regul Integr Comp Physiol (2002) 1.45

Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation. Clin Sci (Lond) (2010) 1.44

Physiological models of body composition and human obesity. Nutr Metab (Lond) (2007) 1.43

Age-related differences in skeletal muscle protein synthesis: relation to markers of immune activation. Am J Physiol Endocrinol Metab (2004) 1.42

Ethnicity-related skeletal muscle differences across the lifespan. Am J Hum Biol (2009) 1.42

Anthropometric correlates of total body fat, abdominal adiposity, and cardiovascular disease risk factors in a biracial sample of men and women. Mayo Clin Proc (2012) 1.41

Combination of BMI and Waist Circumference for Identifying Cardiovascular Risk Factors in Whites. Obes Res (2004) 1.40

Order of magnitude misestimation of weight effects of children's meal policy proposals. Child Obes (2014) 1.39

Dual-energy X-ray absorptiometry is a valid tool for assessing skeletal muscle mass in older women. J Nutr (2007) 1.38

Body fat redistribution after weight gain in women with anorexia nervosa. Am J Clin Nutr (2005) 1.34

Total body potassium differs by sex and race across the adult age span. Am J Clin Nutr (2003) 1.33

A cellular-level approach to predicting resting energy expenditure across the adult years. Am J Clin Nutr (2005) 1.33

Body cell mass: model development and validation at the cellular level of body composition. Am J Physiol Endocrinol Metab (2003) 1.33

Sexual dimorphism of adipose tissue distribution across the lifespan: a cross-sectional whole-body magnetic resonance imaging study. Nutr Metab (Lond) (2009) 1.31

One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures. Health Qual Life Outcomes (2009) 1.28

Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys. Am J Physiol Endocrinol Metab (2006) 1.27

Whole-body skeletal muscle mass: development and validation of total-body potassium prediction models. Am J Clin Nutr (2003) 1.27

Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr (2005) 1.27

The body adiposity index (hip circumference ÷ height(1.5)) is not a more accurate measure of adiposity than is BMI, waist circumference, or hip circumference. Obesity (Silver Spring) (2012) 1.26

Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. J Biol Chem (2010) 1.26